BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 35894054)

  • 1. CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.
    Ruiz-Pablos M
    Pathogens; 2022 Jul; 11(8):. PubMed ID: 35894054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQ
    Li Q; Bu W; Gabriel E; Aguilar F; Hoshino Y; Miyadera H; Hess C; Hornung RL; Roy A; Cohen JI
    JCI Insight; 2017 Feb; 2(4):e85687. PubMed ID: 28239644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
    Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
    Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens.
    Knobloch C; Ballas M; Wölpl A; Friedrich W
    Transplantation; 1992 Jun; 53(6):1295-301. PubMed ID: 1534939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.
    Ressing ME; van Leeuwen D; Verreck FA; Gomez R; Heemskerk B; Toebes M; Mullen MM; Jardetzky TS; Longnecker R; Schilham MW; Ottenhoff TH; Neefjes J; Schumacher TN; Hutt-Fletcher LM; Wiertz EJ
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11583-8. PubMed ID: 14504389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
    Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
    Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients of Mumbai, India.
    Shankarkumar U; Pawar A; Ghosh K; Bajpai S; Pazare A
    Int J Immunogenet; 2010 Jun; 37(3):199-204. PubMed ID: 20345872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
    Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
    Front Immunol; 2019; 10():1568. PubMed ID: 31333679
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
    Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II polymorphism in Egyptian children with lymphomas.
    Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
    Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.
    Haan KM; Longnecker R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9252-7. PubMed ID: 10908662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of MHC class II alleles with insulin-dependent diabetes mellitus (IDDM) in patients from North India.
    Rani R; Sood A; Lazaro AM; Stastny P
    Hum Immunol; 1999 Jun; 60(6):524-31. PubMed ID: 10408802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles.
    Hu CY; Allen M; Chuang LM; Lin BJ; Gyllensten U
    Hum Immunol; 1993 Oct; 38(2):105-14. PubMed ID: 8106265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
    Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
    J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.